Publication | Closed Access

Canakinumab Lacks Efficacy in Treating Adult Patients with Moderate to Severe Chronic Spontaneous Urticaria in a Phase II Randomized Double-Blind Placebo-Controlled Single-Center Study

RheumatologyClinical TrialsClinical DermatologyDermatologyCanakinumab Lacks EfficacyMedicineTreating Adult PatientsClinical Allergy